A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Emerald Clinical Inc.
Hansoh BioMedical R&D Company
Eisai Inc.
Emerald Clinical Inc.
Eleison Pharmaceuticals LLC.
Merck Sharp & Dohme LLC
Novartis
Merck Sharp & Dohme LLC
Oncolytics Biotech
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Eli Lilly and Company
Epeius Biotechnologies
Eli Lilly and Company